NAFDAC issues license to ABUAD to produce COVID-19 immune booster

.. Says drug not a cure but immune booster

THE National Agency for Food and Drug Administration and Control (NAFDAC) has issued a licence to Afe Babalola University to kick-start the production of ABUAD Herbal Virucidine Liquid with effect from December 16, 2021.

The agency confirmed exclusively to The ICIR that the product was an immune booster for COVID-19, not a cure.

The NAFDAC Spokesperson Sayo Akintola confirmed via a text message on Tuesday that the institution had been licensed to go into immune booster production.


Read Also:

Earlier reports had said that the liquid was an immune booster and antioxidant for  coronavirus and other viral infections.

It was reported that the drug could be used as an anti-inflammatory product packaged in 100-ml bottles.

Read Also:

The ICIR can confirm that the new innovation in drug development on COVID-19 is not the first in the country.

In January, the regulatory agency had approved Niprimune as an immune booster, which is produced by the Nigerian Institute for Pharmaceutical Research and Development (NIPRD).

Since its outbreak in late 2019, the pandemic has spread across nations, with several casualties.

Nigeria recently fell into the fourth wave with the recent variant, Omicron.




     

     

    Director of Corporate Affairs of ABUAD Tunde Olofintila, on Tuesday, said with the achievement, ABUAD had joined researchers in some foreign universities making efforts to produce anti-viral medications for the treatment of COVID-19.

    The approval, he revealed, was conveyed in a letter dated December 17, 2021, and signed by the Director-General of NAFDAC, Mojisola Adeyeye.

    Chief Pharmacist of ABUA Toyin Afolabi applauded stakeholders such as the National Universities Commission (NUC), the Medical & Dental Council of Nigeria (MDCN), parents, including both teachers and students, who made the feat possible.

    Also, Chief Medical Director of ABUAD Multi-System Hospital Kolawole Ogundipe sought the industry support for mass production of the immune booster.

    Advertisements

    Olugbenga heads the Investigations Desk at The ICIR. Do you have a scoop? Shoot him an email at [email protected]. Twitter Handle: @OluAdanikin

    Join the ICIR WhatsApp channel for in-depth reports on the economy, politics and governance, and investigative reports.

    Support the ICIR

    We invite you to support us to continue the work we do.

    Your support will strengthen journalism in Nigeria and help sustain our democracy.

    If you or someone you know has a lead, tip or personal experience about this report, our WhatsApp line is open and confidential for a conversation

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here


    Support the ICIR

    We need your support to produce excellent journalism at all times.

    - Advertisement

    Recent

    - Advertisement